Targeting bone cancer with 4-Allylbenzene-1,2-diol purified from Piper betle L.: an in silico and cytotoxicity scrutiny

References

• Ali, A., Chong, C. H., Mah, S. H., Abdullah, L. C., Choong, T. S., & Chua, B. L. (2018). Impact of storage conditions on the stability of predominant phenolic constituents and antioxidant activity of dried Piper betle extracts. Molecules, 23(2), 484. https://doi.org/10.3390/molecules23020484
   PubMed Web of Science ®Google Scholar
• Ali, I., Khan, F. G., Suri, K. A., Gupta, B. D., Satti, N. K., Dutt, P., Afrin, F., Qazi, G. N., & Khan, I. A. (2010). In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. Annals of Clinical Microbiology and Antimicrobials, 9, 7. https://doi.org/10.1186/1476-0711-9-7
   PubMed Web of Science ®Google Scholar
• Amalia, H., Sitompul, R., Hutauruk, J., & Andrianjah, I. A. M. (2009).Effectiveness of Piper betle leaf infusion as a palpebral skin antiseptic. Universa Medicina, 28(2), 83–91.
   Google Scholar
• Amonkar, A. J., Nagabhushan, M., D'Souza, A. V., & Bhide, S. V. (1986). Hydroxychavicol: A new phenolic antimutagen from betel leaf. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 24(12), 1321–1324. https://doi.org/10.1016/0278-6915(86)90065-7
   PubMed Web of Science ®Google Scholar
• Bhattacharya, S., Banerjee, D., Bauri, A. K., Chattopadhyay, S., & Bandyopadhyay, K. (2007). Healing property of the Piper betel phenol, allylpyrocatechol against indomethacin-induced stomach ulceration and mechanism of action. World Journal of Gastroenterology, 13(27), 3705–3713. https://doi.org/10.3748/wjg.v13.i27.3705
   PubMed Web of Science ®Google Scholar
• Biermann, J. S., Chow, W., Reed, D. R., Lucas, D., Adkins, D. R., Agulnik, M., Benjamin, R. S., Brigman, B., Budd, G. T., Curry, W. T., Didwania, A., Fabbri, N., Hornicek, F. J., Kuechle, J. B., Lindskog, D., Mayerson, J., McGarry, S. V., Million, L., Morris, C. D., … Scavone, J. L. (2017). NCCN guidelines insights: Bone cancer, version 2.2017. Journal of the National Comprehensive Cancer Network : JNCCN, 15(2), 155–167. https://doi.org/10.6004/jnccn.2017.0017
   PubMed Web of Science ®Google Scholar
• Binkowski, T. A., Naghibzadeh, S., & Liang, J. (2003). CASTp: Computed atlas of surface topography of proteins. Nucleic Acids Research, 31(13), 3352–3355. https://doi.org/10.1093/nar/gkg512
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., & Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. SC ‘06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing. https://doi.org/10.1145/1188455.1188544
   Google Scholar
• Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E., Sunshine, M. J., Littman, D. R., Kuo, C. J., Wei, K., McMaster, B. E., Wright, K., Howard, M. C., & Schall, T. J. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. The Journal of Experimental Medicine, 203(9), 2201–2213. https://doi.org/10.1084/jem.20052144
   PubMed Web of Science ®Google Scholar
• Chakraborty, J. B., Mahato, S. K., Joshi, K., Shinde, V., Rakshit, S., Biswas, N., Mukherjee, I. C., Mandal, L., Ganguly, D., Chowdhury, A. A., Chaudhuri, J., Paul, K., Pal, B. C., Vinayagam, J., Pal, C., Manna, A., Jaisankar, P., Chaudhuri, U., Konar, A., Roy, S., & Bandyopadhyay, S. (2012). Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. Cancer Science, 103(1), 88–99. https://doi.org/10.1111/j.1349-7006.2011.02107.x
   PubMed Web of Science ®Google Scholar
• Chambers, A., Naumov, G., Varghese, H., Nadkarni, K. V., MacDonald, I. C., & Groom, A. C. (2001). Critical steps in hematogenous metastasis. Surgical Oncology Clinics of North America, 10(2), 243–255. https://doi.org/10.1016/S1055-3207(18)30063-2
   PubMedGoogle Scholar
• Chang, M. C., Uang, B. J., Wu, H. L., Lee, J. J., Hahn, L. J., & Jeng, J. H. (2002). Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species. British Journal of Pharmacology, 135(3), 619–630. https://doi.org/10.1038/sj.bjp.0704492
   PubMed Web of Science ®Google Scholar
• Chowdhury, A. A., Chaudhuri, J., Biswas, N., Manna, A., Chatterjee, S., Mahato, S. K., Chaudhuri, U., Jaisankar, P., & Bandyopadhyay, S. (2013). Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway. PloS One, 8(9), e73672. https://doi.org/10.1371/journal.pone.0073672
   PubMed Web of Science ®Google Scholar
• Colak, S., & Dijke, T. P. (2017). Targeting TGF-β signaling in cancer. Trends in Cancer, 3(1), 56–71. https://doi.org/10.1016/j.trecan.2016.11.008
   PubMed Web of Science ®Google Scholar
• Coleman, R. (2001). Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. Cancer Treatment Reviews, 27(3), 165–176. https://doi.org/10.1053/ctrv.2000.0210
   PubMed Web of Science ®Google Scholar
• Conti, A., Espina, V., Chiechi, A., Magagnoli, G., Novello, C., Pazzaglia, L., Quattrini, I., Picci, P., Liotta, L. A., & Benassi, M. S. (2014). Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways. Clinical & Experimental Metastasis, 31(1), 15–24. https://doi.org/10.1007/s10585-013-9605-6
   PubMed Web of Science ®Google Scholar
• Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology (Clifton, N.J.), 1263, 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
   PubMedGoogle Scholar
• Das, S., Parida, R., Sandeep, I., Nayak, S., & Mohanty, S. (2016). Biotechnological intervention in betelvine (Piper betle L.): A review on recent advances and future prospects. Asian Pacific Journal of Tropical Medicine, 9(10), 938–946. https://doi.org/10.1016/j.apjtm.2016.07.029
   PubMed Web of Science ®Google Scholar
• Felipe, L. O., Bicas, J. L., Bouhoute, M. B., Vodo, S., Taarji, N., Nakajima, M., & Neves, M. A. (2022). Formulation and physicochemical stability of oil-in-water nanoemulsion loaded with α-terpineol as flavor oil using Quillaja saponins as natural emulsifier. Food Research International (Ottawa, Ont.), 153(5), 110894. https://doi.org/10.1016/j.foodres.2021.110894
   PubMedGoogle Scholar
• Fingas, C. D., Mertens, J. C., Razumilava, N., Bronk, S. F., Sirica, A. E., & Gores, G. J. (2012). Targeting PDGFR-β in cholangiocarcinoma. Liver International, 32(3), 400–409.
   PubMed Web of Science ®Google Scholar
• Ganguly, S., Mula, S., Chattopadhyay, S., & Chatterjee, M. (2007). An ethanol extract of Piper betle Linn. mediates its anti-inflammatory activity via down-regulation of nitric oxide. The Journal of Pharmacy and Pharmacology, 59(5), 711–718. https://doi.org/10.1211/jpp.59.5.0012
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Ghosh, R., Nadiminty, N., Fitzpatrick, J. E., Alworth, W. L., Slaga, T. J., & Kumar, A. P. (2005). Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. The Journal of Biological Chemistry, 280(7), 5812–5819. https://doi.org/10.1074/jbc.M411429200
   PubMed Web of Science ®Google Scholar
• Guo, W., Zhang, Z., Li, G., Lai, X., Gu, R., Xu, W., Chen, H., Xing, Z., Chen, L., Qian, J., Xu, S., Zeng, F., & Deng, F. (2020). Pyruvate kinase M2 promotes prostate cancer metastasis through regulating ERK1/2-COX-2 signaling. Frontiers in Oncology, 10, 544288. https://doi.org/10.3389/fonc.2020.544288
   PubMed Web of Science ®Google Scholar
• Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of druglike small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/10.1021/acs.jctc.5b00864
   PubMed Web of Science ®Google Scholar
• Hassan, S. B., Gali-Muhtasib, H., Göransson, H., & Larsson, R. (2010). Alpha Terpineol: A potential anticancer agent which acts through suppressing NF-κB signalling. Anticancer Research, 30(6), 1911–1919.
   PubMed Web of Science ®Google Scholar
• Hiraga, T., Ito, S., & Nakamura, H. (2013). Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Research, 73(13), 4112–4122. https://doi.org/10.1158/0008-5472.CAN-12-3801
   PubMed Web of Science ®Google Scholar
• Humphreys, D. D., Friesner, R. A., & Berne, B. J. (1994). A multiple-time-step molecular dynamics algorithm for macromolecules. The Journal of Physical Chemistry, 98(27), 6885–6892. https://doi.org/10.1021/j100078a035
   Web of Science ®Google Scholar
• Jung, Y., Song, J., Shiozawa, Y., Wang, J., Wang, Z., Williams, B., Havens, A., Schneider, A., Ge, C., Franceschi, R. T., McCauley, L. K., Krebsbach, P. H., & Taichman, R. S. (2008). Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells (Dayton, Ohio), 26(8), 2042–2051. https://doi.org/10.1634/stemcells.2008-0149
   PubMed Web of Science ®Google Scholar
• Kim, J. K., Jung, Y., Wang, J., Joseph, J., Mishra, A., Hill, E. E., Krebsbach, P. H., Pienta, K. J., Shiozawa, Y., & Taichman, R. S. (2013). TBK1 regulates prostate cancer dormancy through mTOR inhibition. Neoplasia (New York, N.Y.), 15(9), 1064–1074. https://doi.org/10.1593/neo.13402
   PubMed Web of Science ®Google Scholar
• Kola, I., & Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates? Nature Reviews. Drug Discovery, 3(8), 711–715. https://doi.org/10.1038/nrd1470
   PubMed Web of Science ®Google Scholar
• Krzeszinski, J., & Wan, Y. (2015). New therapeutic targets for cancer bone metastasis. Trends in Pharmacological Sciences, 36(6), 360–373. https://doi.org/10.1016/j.tips.2015.04.006
   PubMed Web of Science ®Google Scholar
• Kumar, N., Misra, P., Dube, A., Bhattacharya, S., Dikshit, M., & Ranade, S. (2010). Piper betle Linn. a maligned Pan-Asiatic plant with an array of pharmacological activities and prospects for drug discovery. Current Science, 99(7), 922–932.
   Google Scholar
• Lamora, A., Talbot, J., Mullard, M., Brounais-Le Royer, B., Redini, F., & Verrecchia, F. (2016). TGF-β signaling in bone remodeling and osteosarcoma progression. Journal of Clinical Medicine, 5(11), 96. https://doi.org/10.3390/jcm5110096
   PubMed Web of Science ®Google Scholar
• Lei, D., Chan, C. P., Wang, Y. P., Wang, T., Lin, B., Huang, C., Lee, J., Chen, H., Jeng, J., & Chang, M. (2003). Antioxidative and antiplatelet effects of aqueous inflorescence Piper betle extract. Journal of Agricultural and Food Chemistry, 51(7), 2083–2088. https://doi.org/10.1021/jf0210223
   PubMed Web of Science ®Google Scholar
• Lian, L., Li, X., Xu, M., Li, X., Wu, M., Zhang, Y., Tao, M., Li, W., Shen, X. M., Zhou, C., & Jiang, M. (2019). VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer. BMC Cancer, 19(1), 183–198. https://doi.org/10.1186/s12885-019-5322-0
   PubMed Web of Science ®Google Scholar
• Liu, B., Cui, J., Sun, J., Li, J., Han, X., Guo, J., Yi, M., Amizuka, N., Xu, X., & Li, M. (2016). Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells. Molecular Medicine Reports, 14(2), 1099–1106. https://doi.org/10.3892/mmr.2016.5374
   PubMed Web of Science ®Google Scholar
• Manigauha, A., Ali, H., & Maheshwari, M. U. (2009). Antioxidant activity of ethanolic extract of Piper betle leaves. Journal of Pharmacy Research, 2, 491–494.
   Google Scholar
• Martyna, G. J., Klein, M. L., & Tuckerman, M. (1992). Nos\’ e -Hoover chains: The canonical ensemble via continuous dynamics. Journal of Chemical Physics, 97(4), 2635–2643. https://doi.org/10.1063/1.463940
   Web of Science ®Google Scholar
• Martyna, G. J., Tobias, D. J., & Klein, M. L. (1994). Constant pressure molecular dynamics algorithms. Journal of Chemical Physics, 101(5), 4177–4189. https://doi.org/10.1063/1.467468
   Web of Science ®Google Scholar
• Mashhadi, M. A. (2008). Renal side effects of Ifosfamide in patients admitted for chemotherapy. Journal of Research in Medical Sciences, 13, 240–243.
   Web of Science ®Google Scholar
• Nagabhushan, M., Amonkar, A. J., Nair, U. J., D'Souza, A. V., & Bhide, S. V. (1989). Hydroxychavicol: A new anti-nitrosating phenolic compound from betel leaf. Mutagenesis, 4(3), 200–204. https://doi.org/10.1093/mutage/4.3.200
   PubMed Web of Science ®Google Scholar
• Negreiros, H. A., de Moura, K. G., Barreto do Nascimento, M. L. L., do Nascimento Rodrigues, D. C., Ferreir, P. M. P., Braz, D. C., de Farias, M. G., de Sousa Corrêia, L., Pereira, A. R. S., Santos, L. K. B., Gonçalves, J. C. R., Mendes, A. N., Carneiro da Silva, F. C., Cavalcant, A. A. C. M., & de Castro E Sousa, J. M. (2021). Alpha-terpineol as antitumor candidate in pre-clinical studies. Anti-Cancer Agents in Medicinal Chemistry, 21(15), 2023–2031. https://doi.org/10.2174/1871520621999210104195820
   PubMed Web of Science ®Google Scholar
• Ng, P. L., Rajab, N. F., Then, S. M., Mohd Yusof, Y. A., Wan Ngah, W. Z., Pin, K. Y., & Looi, M. L. (2014). Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells. Journal of Zhejiang University. Science. B, 15(8), 692–700. https://doi.org/10.1631/jzus.B1300303
   PubMed Web of Science ®Google Scholar
• Nishiwaki, K., Ohigashi, K., Deguchi, T., Murata, K., Nakamura, S., Matsuda, H., & Nakanishi, I. (2018). Structure-activity relationships and docking studies of hydroxychavicol and its analogs as xanthine oxidase inhibitors. Chemical & Pharmaceutical Bulletin, 66(7), 741–747. https://doi.org/10.1248/cpb.c18-00197
   PubMed Web of Science ®Google Scholar
• Novello, C., Pazzaglia, L., Conti, A., Quattrini, I., Pollino, S., Perego, P., Picci, P., & Benassi, M. S. (2014). p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression. PloS One, 9(12), e114757. https://doi.org/10.1371/journal.pone.0114757
   PubMed Web of Science ®Google Scholar
• Parashar, A., Shukla, A., Sharma, A., Behl, T., Goswami, D., & Mehta, V. (2021). Reckoning γ-Glutamyl-S-allylcysteine as a potential main protease (mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation. Drug Development and Industrial Pharmacy, 47(5), 699–710. https://doi.org/10.1080/03639045.2021.1934857
   PubMed Web of Science ®Google Scholar
• Perret, A., Dômont, J., Chamseddine, A. N., Dumont, S. N., Verret, B., Briand, S., Court, C., Lazure, T., Adam, J., Ngo, C., Even, C., Levy, A., Bayle, A., Lucibello, F., Haddag-Miliani, L., Faron, M., Honoré, C., Le Cesne, A., & Mir, O. (2021). Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma. Cancer Medicine, 10(1), 230–236. https://doi.org/10.1002/cam4.3610
   PubMed Web of Science ®Google Scholar
• Phumat, P., Khongkhunthian, S., Wanachantararak, P., & Okonogi, S. (2020). Comparative inhibitory effects of 4-allylpyrocatechol isolated from Piper betle on Streptococcus intermedius, Streptococcus mutans, and Candida albicans. Archives of Oral Biology, 113, 104690. https://doi.org/10.1016/j.archoralbio.2020.104690
   PubMed Web of Science ®Google Scholar
• Qiu, J., Ishizuka, S., Tonokura, K., Sato, K., Inomata, S., & Enami, S. (2019). Effects of pH on interfacial ozonolysis of α-terpineol. The Journal of Physical Chemistry. A, 123(32), 7148–7155. https://doi.org/10.1021/acs.jpca.9b05434
   PubMed Web of Science ®Google Scholar
• Raghavendra, N. M., Pingili, D., Kadasi, S., Mettu, A., & Prasad, S. (2018). Dual or multi-targeting inhibitors: The next generation anticancer agents. European Journal of Medicinal Chemistry, 143, 1277–1300. https://doi.org/10.1016/j.ejmech.2017.10.021
   PubMed Web of Science ®Google Scholar
• Rahman, A. A., Jamal, A. R., Harun, R., Mohd Mokhtar, N., & Wan Ngah, W. Z. (2014). Gamma-tocotrienol and hydroxychavicol synergistically inhibits growth and induces apoptosis of human glioma cells. BMC Complementary and Alternative Medicine, 14, 213.
   PubMedGoogle Scholar
• Sanderson, R. D., Elkin, M., Rapraeger, A. C., Ilan, N., & Vlodavsky, I. (2017). Heparanase regulation of cancer, autophagy and inflammation: New mechanisms and targets for therapy. The FEBS Journal, 284(1), 42–55. https://doi.org/10.1111/febs.13932
   PubMed Web of Science ®Google Scholar
• Selvaggi, G., & Scagliotti, G. (2005). Management of bone metastases in cancer: a review. Critical Reviews in Oncology/Hematology, 56(3), 365–378. https://doi.org/10.1016/j.critrevonc.2005.03.011
   PubMed Web of Science ®Google Scholar
• Sharma, A., Tiwari, V., & Sowdhamini, R. (2020). Computational search for potential COVID-19 drugs from FDAapproved drugs and small molecules of natural origin identifies several anti-virals and plant products. Journal of Biosciences, 45(1), 100–118. https://doi.org/10.1007/s12038-020-00069-8
   PubMed Web of Science ®Google Scholar
• Trachootham, D., Alexandre, J., & Huang, P. (2009). Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nature Reviews. Drug Discovery, 8(7), 579–591. https://doi.org/10.1038/nrd2803
   PubMed Web of Science ®Google Scholar
• Vyawahare, N. S., Kagathara, V. G., Katedeshmukh, R. G., Sharma, P. K., & Mohod, S. M. (2010). Evaluation of antiulcer activity of Piper betle leaves extract in Rats. Research Journal of Pharmacology and Pharmacodynamics, 2(4), 278–282.
   Google Scholar
• Wang, L., Li, X., Zhang, S., Lu, W., Liao, S., Liu, X., Shan, L., Shen, X., Jiang, H., Zhang, W., Huang, J., & Li, H. (2012). Natural products as a gold mine for selective matrix metalloproteinases inhibitors. Bioorganic & Medicinal Chemistry, 20(13), 4164–4171. https://doi.org/10.1016/j.bmc.2012.04.063
   PubMed Web of Science ®Google Scholar
• Wishart, D. S. (2021). Drug bank, version 5.0. Retrieved October 8, from https://go.drugbank.com/
   Google Scholar
• Yadav, L., Puri, N., Rastogi, V., Satpute, P., Ahmad, R., & Kaur, G. (2014). Matrix metalloproteinases and cancer—Roles in threat and therapy. Asian Pacific Journal of Cancer Prevention : APJCP, 15(3), 1085–1091. https://doi.org/10.7314/apjcp.2014.15.3.1085
   PubMedGoogle Scholar
• Yasuda, K., Torigoe, T., Mariya, T., Asano, T., Kuroda, T., Matsuzaki, J., Ikeda, K., Yamauchi, M., Emori, M., Asanuma, H., Hasegawa, T., Saito, T., Hirohashi, Y., & Sato, N. (2014). Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity. Laboratory Investigation; A Journal of Technical Methods and Pathology, 94(12), 1355–1369. https://doi.org/10.1038/labinvest.2014.122
   PubMed Web of Science ®Google Scholar